Received May 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 3ER79 | — |
A 60 years old female patient received only the sterile water portion of Priorix.; A 60 years old female patient received only the sterile water portion of Priorix.; A 60 years old female patient received Priorix; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 60-year-old female patient who received MMR (Priorix) (batch number 3ER79, expiry date 28-NOV-2028) for prophylaxis. On an unknown date, the patient received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: A 60 years old female patient received only the sterile water portion of Priorix.), inappropriate dose of vaccine administered (Verbatim: A 60 years old female patient received only the sterile water portion of Priorix.) and inappropriate age at vaccine administration (Verbatim: A 60 years old female patient received Priorix). The outcome of the inappropriate preparation of medication, inappropriate dose of vaccine administered and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 22-APR-2025 The nurse manager reported that they administered only the sterile water component of Priorix to a patient, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The Lot number was 2JX7Y and expiration date 01st June 2026 of Priorix that was not administered. The reporter asked was there any potential harm to the patient. The patient received a dose of Priorix at an inappropriate age, which led to inappropriate age at vaccine administration.